Patents by Inventor John P. Leonard

John P. Leonard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220409595
    Abstract: The invention relates to inhibitors of glucosylceramide synthase (GCS) useful for the treatment of metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy.
    Type: Application
    Filed: May 25, 2022
    Publication date: December 29, 2022
    Inventors: John P. LEONARD, Jean-François DELEUZE, Jean-Michel ITIER, Cécile ORSINI, Gwénaëlle RET-LECUELLE, Sandra VIALE
  • Publication number: 20220260441
    Abstract: Provided herein is technology relating to measuring and recording weather phenomena and particularly, but not exclusively, to apparatuses, methods, kits, and systems for measuring hydrometeor impacts, e.g., hail impacts.
    Type: Application
    Filed: July 28, 2020
    Publication date: August 18, 2022
    Inventors: Bryan A. Dow, John P. Leonard
  • Publication number: 20210405254
    Abstract: Provided herein is technology relating to measuring weather data and particularly, but not exclusively, to apparatuses, methods, and systems for sensing hydrometeors (e.g., rain) and measuring hydrometeor characteristics (e.g., volume, rate, size distribution, etc.).
    Type: Application
    Filed: November 5, 2019
    Publication date: December 30, 2021
    Inventors: John P. Leonard, Kyle Z. Jero, Bryan A. Dow, Eric J. Hewitt
  • Publication number: 20210261557
    Abstract: The invention relates to inhibitors of glucosylceramide synthase (GCS) useful for the treatment of metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, and for the treatment of cancer.
    Type: Application
    Filed: April 27, 2021
    Publication date: August 26, 2021
    Applicant: GENZYME CORPORATION
    Inventors: Elyse BOURQUE, Mario CABRERA-SALAZAR, Cassandra CELATKA, Seng CHENG, Mary A. CROMWELL, Andrew GOOD, Bradford HIRTH, Katherine JANCSICS, John P. LEONARD, Lingyun LI, James LILLIE, Hanlan LIU, Elina MAKINO, John MARSHALL, Paul MASON, Markus METZ, Fazeela MORSHED, Thomas O'SHEA, Ronald SCHEULE, Renato SKERLJ, Bing WANG, Yibin XIANG, Zhong ZHAO
  • Publication number: 20200142099
    Abstract: Provided herein is technology relating to measuring weather data and particularly, but not exclusively, to apparatuses, methods, and systems for sensing hydrometeors (e.g., rain) and measuring hydrometeor characteristics (e.g., volume, rate, size distribution, etc.).
    Type: Application
    Filed: November 5, 2019
    Publication date: May 7, 2020
    Inventors: John P. Leonard, Kyle Z. Jero, Bryan A. Dow, Eric J. Hewitt
  • Publication number: 20200048266
    Abstract: The invention relates to inhibitors of glucosylceramide synthase (GCS) useful for the treatment of metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, and for the treatment of cancer.
    Type: Application
    Filed: August 15, 2019
    Publication date: February 13, 2020
    Inventors: Elyse BOURQUE, Mario CABRERA-SALAZAR, Cassandra CELATKA, Seng CHENG, Mary A. CROMWELL, Andrew GOOD, Bradford HIRTH, Katherine JANCSICS, John P. LEONARD, Lingyun LI, James LILLIE, Hanlan LIU, Elina MAKINO, John MARSHALL, Paul MASON, Markus METZ, Fazeela MORSHED, Thomas O'SHEA, Ronald SCHEULE, Renato SKERLJ, Bing WANG, Yibin XIANG, Zhong ZHAO
  • Patent number: 10220039
    Abstract: A method of treating polycystic kidney disease in a subject comprises administering to the subject an effective amount of a compound represented by Structural Formula (1): or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: January 25, 2017
    Date of Patent: March 5, 2019
    Assignee: Genzyme Corporation
    Inventors: Thomas A. Natoli, Oxana Ibraghimov-Beskrovnaya, John P. Leonard, Nelson S. Yew, Seng H. Cheng
  • Publication number: 20190046509
    Abstract: The invention relates to inhibitors of glucosylceramide synthase (GCS) useful for the treatment metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy.
    Type: Application
    Filed: April 5, 2018
    Publication date: February 14, 2019
    Inventors: JOHN P. LEONARD, JEAN-FRANÇOIS DELEUZE, JEAN-MICHEL ITIER, CÉCILE ORSINI, GWÉNAËLLE RET-LECUELLE, SANDRA VIALE
  • Publication number: 20170258802
    Abstract: A method of treating polycystic kidney disease in a subject comprises administering to the subject an effective amount of a compound represented by Structural Formula (1): or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: January 25, 2017
    Publication date: September 14, 2017
    Inventors: Thomas A. Natoli, Oxana Ibraghimov-Beskrovnaya, John P. Leonard, Nelson S. Yew, Seng H. Cheng
  • Publication number: 20160361301
    Abstract: The invention relates to inhibitors of glucosylceramide synthase (GCS) useful for the treatment metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy.
    Type: Application
    Filed: December 9, 2014
    Publication date: December 15, 2016
    Inventors: JOHN P. LEONARD, JEAN-FRANÇOIS DELEUZE, JEAN-MICHEL ITIER, CÉCILE ORSINI, GWÉNAËLLE RET-LECUELLE, SANDRA VIALE
  • Publication number: 20160207933
    Abstract: The invention relates to inhibitors of glucosylceramide synthase (GCS) useful for the treatment metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, and for the treatment of cancer.
    Type: Application
    Filed: August 25, 2015
    Publication date: July 21, 2016
    Inventors: Elyse BOURQUE, Mario CABRERA-SALAZAR, Cassandra CELATKA, Seng CHENG, Mary A. CROMWELL, Andrew GOOD, Bradford HIRTH, Katherine JANCSICS, John P. LEONARD, Lingyun LI, James LILLIE, Hanlan LIU, Elina MAKINO, John MARSHALL, Paul MASON, Markus METZ, Fazeela MORSHED, Thomas O'SHEA, Ronald SCHEULE, Renato SKERLJ, Bing WANG, Yibin XIANG, Zhong ZHAO
  • Patent number: 9139580
    Abstract: The invention relates to inhibitors of glucosylceramide synthase (GCS) useful for the treatment metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, and for the treatment of cancer.
    Type: Grant
    Filed: September 18, 2013
    Date of Patent: September 22, 2015
    Assignee: Genzyme Corporation
    Inventors: Elyse Bourque, Bradford Hirth, Renato Sklerj, Elina Makino, Fazeela Morshed, Lingyun Li, Paul Mason, John P. Leonard, James Lillie, Hanlan Liu, Mary A. Cromwell, Bing Wang, Thomas O'Shea
  • Patent number: 9126993
    Abstract: The invention relates to inhibitors of glucosylceramide synthase (GCS) useful for the treatment metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, and for the treatment of cancer.
    Type: Grant
    Filed: August 28, 2014
    Date of Patent: September 8, 2015
    Assignee: Genzyme Corporation
    Inventors: Elyse Bourque, Bradford Hirth, Renato Sklerj, Elina Makino, Fazeela Morshed, Lingyun Li, Paul Mason, John P. Leonard, James Lillie, Hanlan Liu, Mary A. Cromwell, Bing Wang, Thomas O'Shea
  • Publication number: 20150216872
    Abstract: A method of treating polycystic kidney disease in a subject comprises administering to the subject an effective amount of a compound represented by Structural Formula (1): or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: November 4, 2014
    Publication date: August 6, 2015
    Inventors: Thomas A. Natoli, Oxana Ibraghimov-Beskrovnaya, John P. Leonard, Nelson S. Yew, Seng H. Cheng
  • Patent number: 8912177
    Abstract: A method of treating polycystic kidney disease in a subject comprises administering to the subject an effective amount of a compound represented by Structural Formula (1): or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: October 3, 2008
    Date of Patent: December 16, 2014
    Assignee: Genzyme Corporation
    Inventors: Thomas A. Natoli, Oxana Ibraghimov-Beskrovnaya, John P. Leonard, Nelson S. Yew, Seng H. Cheng
  • Publication number: 20100298317
    Abstract: A method of treating polycystic kidney disease in a subject comprises administering to the subject an effective amount of a compound represented by Structural Formula (1): or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: October 3, 2008
    Publication date: November 25, 2010
    Inventors: Thomas A. Natoli, Oxana Ibraghinov-Beskrovnaya, John P. Leonard, Nelson S. Yew, Seng H. Cheng
  • Patent number: 7138115
    Abstract: Method of treating autoimmune conditions are disclosed comprising administering to a mammalian subject IL-12 or an IL-12 antagonist. In certain preferred embodiments the autoimmune condition is one which is promoted by an increase in levels of IFN-? or TNF-?. Suitable conditions for treatment include multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, autoimmune pulmonary inflammation, Guillain-Barre syndrome, autoimmune thyroiditis, insulin dependent diabetes melitis and autoimmune inflammatory eye disease.
    Type: Grant
    Filed: September 11, 2003
    Date of Patent: November 21, 2006
    Assignee: Genetics Institute, LLC
    Inventors: John P. Leonard, Samuel Goldman, Richard O'Hara, Jr.
  • Patent number: 5174539
    Abstract: A bracket for mounting components in a housing in which a first set of two legs extend from and substantially perpendicular to one surface of a plate and a second set of at least two legs extend from and perpendicular to the opposite surface of the plate. The bracket is connectable to the floor of the housing to support a first component at a predetermined height in said housing and is reversible to support a component of a greater height than the first component.
    Type: Grant
    Filed: October 6, 1991
    Date of Patent: December 29, 1992
    Assignee: Tandy Corporation
    Inventor: John P. Leonard
  • Patent number: 4383662
    Abstract: Apparatus and method of anti-armor missile trajectory shaping for optimum rhead penetration of armor by a guided missile. The guidance system utilizes a terminal homing guidance unit in conjunction with a programmed control signal through the missile's autopilot to cause the missile to cruise at low altitudes and then dive onto the armor target. The terminal dive angle can be selected dependent upon the target's armor characteristics.
    Type: Grant
    Filed: March 13, 1978
    Date of Patent: May 17, 1983
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: Robert E. Alongi, Robert E. Yates, John P. Leonard
  • Patent number: 4277038
    Abstract: In a missile system, a simple way to guide a missile in a predetermined tectory from launch to the impacting with a target for optimum warhead penetration of armor by a guided missile. Initially, the missile is guided in yaw by proportional navigation. Subsequently it is guided in pitch first by a pitch programmer until the missile reaches a predetermined gimbal angle between a line of sight of a seeker of the missile and a centerline of the missile, then in pitch by a pseudo-time-optimal closed loop controller to direct the missile pitch attitude at a predetermined rate toward a target until said missile reaches another predetermined gimbal angle, and finally by proportional navigation in pitch of the missile to the target.
    Type: Grant
    Filed: April 27, 1979
    Date of Patent: July 7, 1981
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: Robert E. Yates, John P. Leonard, Robert E. Alongi, Wilfredo V. Albanes, Charles M. Bishop